Pharmacetical Tech

Weekly Updates
08th November 2013

Press Releases
Furiex Pharmaceuticals Announces Priligy® Launch in the United Kingdom by Menarini

MOCON, Inc. (NASDAQ:MOCO) announced today that on October 25, 2013, the Minneapolis/St. Paul Business Journal named MOCON, Inc. to its list of the top twenty-five fastest growing public companies in Minnesota. MOCON was ranked number ten on the list which assessed the companies by annualized three year revenue growth. MOCON’s average annual growth rate over its last three fiscal years was 23.3%.

ProNAi to Present Phase II Clinical Data at ASH for PNT2258, a BCL2 Targeted Drug

ProNAi Therapeutics, Inc. a leader in nucleic acid therapeutics, announced that data from its ongoing Phase II clinical study of PNT2258, a novel BCL2 inhibitor, will be presented at the 55th Annual Meeting of the American Society of Hematology (ASH), held in New Orleans December 7-10, 2013. “We are very encouraged by the safety profile and the anti-tumor responses in patients with relapsed or refractory non-Hodgkin’s lymphoma (NHL) treated with PNT2258,” stated Rich Messmann, ProNAi’s Chief Medical Officer.

Santarus and Pharming Announce New Data from Open-Label Repeat Treatment Study with RUCONEST (Recombinant Human C1 Esterase Inhibitor)

Santarus, Inc. (NASDAQ:SNTS) and Pharming Group NV (NYSE Euronext: PHARM) announced that new data from an open-label extension of the pivotal Phase III clinical study with RUCONEST® (recombinant human C1 esterase inhibitor, or rhC1INH) will be featured in a poster presentation on November 9 & 10, 2013 at the 2013 American College of Allergy, Asthma & Immunology Annual Scientific Meeting at the Convention Center in Baltimore, Maryland.

Prosensa Enrolls 100th Patient to its Natural History Study of Duchenne Muscular Dystrophy

Prosensa Holding N.V. (NASDAQ: RNA), the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, today announced the successful enrollment of the 100th patient into the Natural History Study of Duchenne muscular dystrophy (DMD). The goal of this observational study is to characterize DMD at various stages of progression using the same measures used in ongoing clinical studies, such as the "six minute walk test." No medication is being tested in this study.

Hurdles to Global Pharma Markets Growth

One of the premium industrial segments ever and one such industry on which many nations across the globe have relied upon for boosting the economic development is Pharma Industry. However, when we dwell in to the insights, this is one of the most regulated industries and of course it has to be, as it is directly related to the lives of many.

Finding the Right Psychiatrist

Recommendations can be gained from many sources such as a primary care doctor or friends who have seen particular psychiatrists. Getting a recommendation from a primary care doctor is a good idea, as they have a good insight into the situation and can possibly guide people towards the right psychiatrist for their particular needs.

Clinical Research Ethical or Unethical

Everybody believes that informed consent makes clinical research ethical. However, informed consent is neither necessary nor sufficient for ethical clinical research. Drawing on the basic philosophies underlying major codes, declarations, and other documents relevant to research with human subjects, The aspects which make Clinical Research Ethical:

Are Vaccines worth the Cash?

Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth

The Travel Vaccines Market is Forecast to Grow at a CAGR of 7.5% from 2012 to 2019

Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth

Pamasol Willi Mäder AG

The Pamasol company was formed in Switzerland and for 50 years has been setting pioneering technological standards in the aerosol industry. In the future as well, Pamasol is depending on high quality and gearing itself to its successful origins in mechanical engineering.

PCI Analytics Pvt. Ltd.

PCI Analytics Pvt. Ltd. is involved in manufacturing wide range of Gas handling Equipments, analytical Instruments, Attachments, and Accessories etc. since 1994. PCI Analytics Pvt. Ltd. is one of the leading suppliers of Accessories, consumables, spares for GC, HPLC, FTIR, AAS, ICP-MS, UV-VISIBLE Spectrophoto meter and other Analytical Instruments.

Bioquell Asia Pacific Pte Ltd

Bioquell specialise in the design, manufacture and application of complete bio-decontamination solutions for airborne and surface contamination in the healthcare, life sciences, food production and defence sectors. Bioquell's unique hydrogen peroxide vapour (HPV) bio-decontamination technology has been used across the globe to eradicate problematic bacteria, viruses and fungi, throughout a wide range of applications.

Event and Exhibitions
Clinical Trial Supply Southern California 2013

Clinical Trial Supply Southern California returns for its 4th year and after the success of last year’s conference, the 2013 event is set to be the perfect forum for discussion and debate into the biggest challenges facing the clinical supply chain.

2nd World Biosimilar Congress 2013

As the pharmaceutical industry as a whole takes an ever-increasing look at the advent and implications of biosimilar medicines, now is an important time to ensure you are at the forefront of knowledge in the biosimilar space. Make sure you understand the full scope of considerations in developing biosimilars

4th Annual World Orphan Drug Congress 2013

As Europe’s longest running commercial congress, it is officially Europe’s largest forum bridging clinical, designation, market access, reimbursement and corporate development aims. With unrivalled endorsement from industry’s leading rare disease and orphan drug developers, this event brings the Who’s Who of the orphan drug Biopharma community.

Follow Us:

Twitter Twitter Facebook Facebook

Click here to unsubscribe from the newsletter
Ochre Media Pvt. Ltd., Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Andhra Pradesh, India.